These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22213215)

  • 1. Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.
    Jones K; Nourse JP; Keane C; Crooks P; Gottlieb D; Ritchie DS; Gill D; Gandhi MK
    Am J Hematol; 2012 Mar; 87(3):258-65. PubMed ID: 22213215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
    Ito Y; Kimura H; Maeda Y; Hashimoto C; Ishida F; Izutsu K; Fukushima N; Isobe Y; Takizawa J; Hasegawa Y; Kobayashi H; Okamura S; Kobayashi H; Yamaguchi M; Suzumiya J; Hyo R; Nakamura S; Kawa K; Oshimi K; Suzuki R
    Clin Cancer Res; 2012 Aug; 18(15):4183-90. PubMed ID: 22675173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Barkholt L; Linde A; Falk KI
    Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease.
    Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au SK; Law CK; Lau WH
    Clin Cancer Res; 2002 Apr; 8(4):986-94. PubMed ID: 11948104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
    Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
    J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
    Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM
    Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.
    Wang WY; Twu CW; Lin WY; Jiang RS; Liang KL; Chen KW; Wu CT; Shih YT; Lin JC
    Cancer; 2011 Oct; 117(19):4452-9. PubMed ID: 21437892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.
    Lin JC; Wang WY; Chen KY; Wei YH; Liang WM; Jan JS; Jiang RS
    N Engl J Med; 2004 Jun; 350(24):2461-70. PubMed ID: 15190138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
    Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
    Haque T; Chaggar T; Schafers J; Atkinson C; McAulay KA; Crawford DH
    J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
    Tan EL; Looi LM; Sam CK
    Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
    Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Epstein-Barr virus DNA in plasma and lymph node biopsy samples of pediatric and adult patients with Hodgkin lymphoma.
    Pajand O; Pourakbari B; Mahjob F; Aghamohammadi A; Mamishi N; Mamishi S
    Pediatr Hematol Oncol; 2011 Feb; 28(1):10-5. PubMed ID: 21083364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.